Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × plitidepsin × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Neoplasm Metastasis 1 Liposarcoma 1

Interventions

Cyclophosphamide 37 Peripheral Blood Stem Cell Transplantation 27 fludarabine phosphate 26 Filgrastim 23 Cyclosporine 22 Busulfan 22 Mycophenolic Acid 21 Radiotherapy 20 Antilymphocyte Serum 20 Melphalan 14 Whole-Body Irradiation 13 Methylprednisolone 13 Tacrolimus 12 Cord Blood Stem Cell Transplantation 12 Methotrexate 11 Etoposide 8 Sirolimus 5 Rituximab 5 Bevacizumab 5 aldesleukin 4 Thiotepa 4 Temozolomide 4 Granulocyte Colony-Stimulating Factor 4 sargramostim 3 Topotecan 3 Therapeutics 3 Polymerase Chain Reaction 3 Irinotecan 3 Cytarabine 3 Carmustine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01876043 2021-01-25

APLIPO

Institut Bergonié

Phase 2 Terminated

24 enrolled 10 charts

Liposarcoma, Neoplasm Metastasis, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡